About Us

Company Profile

ChromX Health Co., Ltd.‌, founded in 2021 by Dr. Junqi Wang—a Yale University postdoctoral researcher and University of Michigan Ph.D. holder—is a Guangzhou-based innovator revolutionizing non-invasive diagnostics through breath analysis. As a National High-Tech Enterprise and a core participant in China's Disruptive Technology Innovation Program, the company has developed the world's first chip-based miniaturized gas chromatograph by integrating MEMS, microfluidic, and AI technologies. This breakthrough achieves parts-per-trillion (ppt) sensitivity, surpassing international benchmarks while reducing equipment costs compared to traditional systems.Founded in 2021 by Dr. Junqi Wang, Yale University postdoctoral fellow and University of Michigan Ph.D. graduate. We're a venture-backed breath diagnostics pioneer delivering the world's first NMPA Class II-certif ied micro gas chromatograph. Our MEMS-Microf luidic-AI integrated system achieves unprecedented parts-per-trillion (ppt) level VOC detection accuracy, thereby powering clinical solutions across early cancer screening, chronic disease management, and ICU monitoring throughcollaborations with 30+ domestic and international medical institutions.

Dr. Wang/ Founder and CEO

Dr. Wang Junqi, a postdoctoral fellow from Yale University and Ph.D. in Analytical Chemistry from the University of Michigan, stands as a leading figure in global micro gas chromatography (micro-GC) technology. He co-founded and spearheaded the commercialization of two U.S.-based companies, Targeted Compound Monitoring, LLC and HKF Technology, where he served as Chief Technology Officer to develop core technologies and products for HKF. With 18 published papers, including 8 in Chinese Academy of Sciences Tier-1 journals, his groundbreaking research has been featured in top-tier publications such as Nature's Microsystems & Nanoengineering and Analytical Chemistry. He has delivered keynote speeches at prestigious international conferences like IEEE Transducers & Eurosensors, and has been invited to share insights at Harvard University, Yale University, Merck & Co., and The Dow Chemical Company.

Recognized as a National Entrepreneurial Talent by China's Ministry of Industry and Information Technology, Dr. Wang leads multiple national innovation initiatives, including the National Disruptive Technology Innovation Key Project and the Key Entrepreneurial Program for Overseas Returnees under the Ministry of Human Resources. He has been honored as Guangzhou's Innovation and Entrepreneurship Leader and included in the Guangzhou Science and Technology Experts Database. His accolades span prestigious titles such as Fortune China's "40 Under 40 Most Promising Business Leaders," "Top 10 Rising Stars in Guangdong Business," "36Under36 Entrepreneurial Pioneer" by 36Kr, and "2023 Innovator of the Year" among the Top 50 Biotech Innovators in the Greater Bay Area. Currently, he serves as Executive Council Member of the Chinese Research Hospital Association and Standing Director of the Youth Committee at the Guangdong Chamber of Commerce, driving cross-industry collaboration and scientific innovation.

Stone/ CDO

Master of Biomedical Informatics at Harvard Medical School, Bachelor of Science in Computer Science and Molecular Biology at McGill University. He is experienced in interdisciplinary research and application of AI+Medicine , especially in the integration of multiomics for better clinical decision support. He has carried out scientific research work in world-class interdisciplinary research centers such as Mila Institute and Dana-Farber Cancer Institude. Several patented AI+Medicine algorithms, which he either led or developed as core staff, have been applied to large medical platforms such as Pingan Good Doctor and Kingmed Diagnostics.

Dr.Fan/ Chief Technical Advisor

Tenured Professor in the Biomedical Engineering Department at the University of Michigan (# 17 in the world, US News 2021) who has published more than 180 papers in Nature Photonics, Nature Biomedical Engineering, Nature Methods, Nature Communications, PNAS and academic journals, whose papers have been cited more than 15,000 times. He is IEEE Fellow of the Institute of Electrical and Electronics Engineers, Fellow of the Royal Society of Chemistry (FRSC), Fellow of the International Society of Optical Engineering (SPIE), and Distinguished Professor of ChangJiang Scholars Award Program of the Ministry of Education.

Leon/ Product Development Manager

Master of Electronic and Communication Engineering from Sun Yat-sen University, with CFDA Certification of Medical Electrical Equipment Safety Inspection, Medical Device Software Registration Technical Examination and Standard Inspection. He has 20 years of experience in product research and development, he has more than 10 years of experience in medical device product research and development. He used to serve as the Core R&D Engineer and Product R&D Manager in listed medical device companies with over 40 patented technologies and rich project experience in hardware design and software development.

Jill / Strategic analyst

Master of Regional Economics at Sun Yat-sen University, Bachelor of Economics at Zhongnan University of Economics and Law. She has a deep understanding of strategic analysis frameworks and industry research methods from her many years of involvement in the corresponding field. She has participated in strategic planning projects for many healthcare customers, in which she provided scientific solutions for strategic positioning, business planning, and goal formulation.